Previous 10 | Next 10 |
Lantheus Holdings (LNTH) has climbed ~21.0% in the premarket after announcing the FDA approval for PYLARIFY in the identification of suspected metastasis or recurrence of prostate cancer.PYLARIFY is an F 18-labeled prostate-specific membrane antigen ((PSMA)) targeted posit...
PYLARIFY will be available immediately to imaging centers in parts of the mid-Atlantic and southern regions and is expected to be broadly available throughout the U.S. by year end Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors enter next week prepped for more volatility with risk assets after the cryptocurrency plunge. The negative vib...
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Satu...
Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to find, fight and follow serious medical conditions, announced today ...
Lantheus Holdings, Inc. (LNTH) Q1 2021 Results Earnings Conference Call May 04, 2021, 08:00 AM ET Company Participants Mark Kinarney - Senior Director of Investor Relations Mary Anne Heino - President and Chief Executive Officer Robert Marshall - Chief Financial Officer and Treasurer Conferen...
The following slide deck was published by Lantheus Holdings, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Lantheus Holdings, Inc. 2021 Q1 - Results - Earnings Call Presentation
Image source: The Motley Fool. Lantheus Holdings Inc (NASDAQ: LNTH) Q1 2021 Earnings Call May 4, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Lantheus Holdings Inc (LNTH) Q1 2021 Earnings Call Transcript
Lantheus (NASDAQ:LNTH) is scheduled to announce Q1 earnings results on Tuesday, May 4th, before market open.The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $87.24M (-3.8% Y/Y).Over the last 2 years, LNTH has beaten EPS estimates 100% of the time and has beaten ...
[[AME]], [[APO]], [[ARCB]], [[ARNC]], [[ATC]], [[BEN]], [[BEP]], [[BERY]], [[BG]], [[BHC]], [[BR]], [[CMI]], [[COP]], [[CQP]], [[CRL]], [[CRSR]], [[CTLT]], [[CVLT]], [[CVS]], [[CWH]], [[D]], [[DD]], [[DEA]], [[ETN]], [[ETRN]], [[EXPD]], [[FI]], [[FSS]], [[GCP]], [[GPN]], [[HEP]], [[HSC]], [[H...
News, Short Squeeze, Breakout and More Instantly...
Lantheus Holdings Inc. Company Name:
LNTH Stock Symbol:
NASDAQ Market:
Lantheus Holdings Inc. Website:
BEDFORD, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Wednesday, July 31, 2024, to discuss its financial and operating results for the second...
BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced its acqu...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...